Demeclocycline NEW
| Price | $38 | $82 | $118 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-10-26 |
Product Details
| Product Name: Demeclocycline | CAS No.: 127-33-3 |
| Purity: 97.46% | Supply Ability: 10g |
| Release date: 2025/10/26 |
Product Introduction
Bioactivity
| Name | Demeclocycline |
| Description | Demeclocycline (Declostatin) is a tetracycline antibiotic produced by a strain of Streptomyces aureofaciens.Demeclocycline has antimicrobial activity and inhibits the action of vasopressin on the renal tubules, leading to diuresis. Demeclocycline can be used to induce diuresis and acute renal failure. |
| In vitro | Demeclocycline (10 μM; 24 h) is a novel BTICs growth inhibitor, which can directly stimulate the activity of monocytes and macrophages[4]. |
| In vivo | Demeclocycline (40 mg/kg; intraperitoneal injection; once daily; for 48 hours) resulted in increased urine volume, decreased urine osmolality, and significantly increased fractional excretion of water[3]. |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 20 mg/mL (43.02 mM), Sonication is recommended. DMSO : 10 mg/mL (21.51 mM), Sonication is recommended. |
| Keywords | Demeclocycline | Antibacterial |
| Inhibitors Related | Neomycin sulfate | Adipic dihydrazide | Ampicillin sodium | Acetic Acid | Kanamycin sulfate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Metronidazole | Copper(Ⅱ) Sulfate | Doxycycline | Trisodium Phosphate | BES |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | ReFRAME Related Library | Drug Repurposing Compound Library | Microbial Natural Product Library | Anti-Bacterial Compound Library | FDA-Approved Drug Library | Natural Product Library for HTS | Anti-infective Natural Product Library | Bioactive Compounds Library Max | Anti-Infection Compound Library | Human Metabolite Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1KG |
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-24 | |
| $0.00/10mg |
VIP8Y
|
Guangzhou PI PI BIOTECH INC
|
2022-04-23 | |
| $0.00/1kg |
VIP3Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2023-07-04 | |
| $38.00/1mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-10-26 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY